implanted device (cardiology) Archives

Target-Lesion Failure Reduced After MI With Biodegradable Stent

March 16, 2021 acute myocardial infarction, ami, anti-cancer agents, antineoplastic drug, bevacizumab, biventricular, drug-eluting stent, erlotinib, gefitinib, imatinib, implanted device (cardiology), myocardial infarction, Rituximab, st segment elevation mi, st segment elevation myocardial infarction, stemi, stent, su11248, sunitinib, target lesion revascularization, tlr (target lesion revascularization), trastuzumab

For a primary composite target-lesion failure outcome, a biodegradable polymer sirolimus-eluting stent showed superiority at 2 years over a durable

Health News

BASILICA Technique Prevents TAVR-Related Coronary Obstruction

March 12, 2021 aortic stenosis, biv, biventricular pacing, Blood, cardiac resynchronization therapy, cerebrovascular accident, crt, cva (cerebrovascular accident), heart, hypotension, implanted device (cardiology), percutaneous aortic valve replacement, stent, Stroke, surgery, transcatheter aortic valve implantation (TAVI), transcatheter aortic valve replacement (TAVR)

For patients undergoing transcatheter aortic valve replacement (TAVR), the intentional laceration technique of diseased valve leaflets called BASILICA is effective